Guangdong Kanghua Healthcare Co., Ltd. (3689.HK)
HKD 2.0
(0.0%)
HKD 2.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 204.19 Million | 221.4 Million | 333.36 Million | 275.29 Million | 98.17 Million | 176.96 Million |
| Net Income | 153.42 Million | 69.3 Million | 129.2 Million | -26.08 Million | 117.48 Million | 221.75 Million |
| Depreciation & Amortization | 143.07 Million | 149.44 Million | 149.44 Million | 142.88 Million | 122.6 Million | 71.61 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -45.98 Million | 57.55 Million | 76.18 Million | 112.58 Million | -120.82 Million | -30.19 Million |
| Other non-cash items | 8.13 Million | -54.89 Million | -21.46 Million | 45.9 Million | -21.08 Million | -86.21 Million |
| Investing Cash Flow | -107.72 Million | -83.15 Million | -299.33 Million | -182.15 Million | -212.88 Million | -285.38 Million |
| Investments in PPE | -130.88 Million | -115.2 Million | -171.17 Million | -247.53 Million | -218.99 Million | -90.32 Million |
| Acquisitions | -115.72 Million | -621 Thousand | 2.64 Million | 4.82 Million | -20.95 Million | -294.49 Million |
| Investment purchases | -1.05 Billion | -1.01 Billion | -2.9 Billion | -1.6 Billion | -1.67 Billion | -1.85 Billion |
| Sales/Maturities of investments | 1.19 Billion | 1.06 Billion | 2.78 Billion | 1.66 Billion | 1.68 Billion | 1.94 Billion |
| Other Investing Activities | -453 Thousand | -15.62 Million | -1.41 Million | 1.16 Million | 21.77 Million | 7.24 Million |
| Financing Cash Flow | -55.56 Million | -110.88 Million | 23.26 Million | -138.21 Million | 135.1 Million | -74.42 Million |
| Debt repayment | -35.24 Million | -32.93 Million | -9.76 Million | -16.23 Million | -14.66 Million | -60 Million |
| Dividends payments | - | - | - | - | -53.36 Million | -54.23 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -26.86 Million | -77.94 Million | 33.02 Million | -121.98 Million | 203.12 Million | 39.8 Million |
| Accounts receivables | -16.16 Million | -16.88 Million | -23.05 Million | 53.35 Million | -94.22 Million | -17.59 Million |
| Accounts payables | - | 16.88 Million | 23.05 Million | -53.35 Million | 94.22 Million | - |
| Inventory | 14.77 Million | -2.8 Million | -27.18 Million | 13.01 Million | -24.41 Million | 4.07 Million |
| Other working capital | -44.59 Million | 60.35 Million | 103.36 Million | 99.57 Million | -96.41 Million | -34.26 Million |
| Cash at beginning of period | 264.33 Million | 237.34 Million | 179.67 Million | 223.88 Million | 203.25 Million | 383.79 Million |
| Cash at end of period | 305.17 Million | 264.33 Million | 237.34 Million | 179.67 Million | 223.88 Million | 203.25 Million |
| Capital Expenditure | -130.88 Million | -115.2 Million | -171.17 Million | -247.53 Million | -218.99 Million | -90.32 Million |
| Effect of forex changes on cash | -74 Thousand | -371 Thousand | 364 Thousand | 868 Thousand | 223 Thousand | 2.3 Million |
| Net cash flow / Change in cash | 40.83 Million | 26.99 Million | 57.67 Million | -44.2 Million | 20.62 Million | -180.54 Million |
| Free Cash Flow | 73.31 Million | 106.2 Million | 162.19 Million | 27.75 Million | -120.81 Million | 86.63 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.77 Million | -9.77 Million | 35.2 Million | 153.42 Million | 35.2 Million | 25.32 Million |
| Depreciation & Amortization | 37.53 Million | 37.53 Million | 35.55 Million | 143.07 Million | 35.55 Million | 36.48 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -696 Thousand | -45.98 Million | -696 Thousand | - |
| Other non-cash items | -3.37 Million | -3.37 Million | 750 Thousand | 8.13 Million | 750 Thousand | -30.52 Million |
| Investing Cash Flow | -24.91 Million | -24.91 Million | -63.03 Million | -107.72 Million | -63.03 Million | 9.17 Million |
| Investments in PPE | -24.63 Million | -24.63 Million | -24.25 Million | -130.88 Million | -24.25 Million | -41.18 Million |
| Acquisitions | 3.06 Million | 3.06 Million | -57.87 Million | -115.72 Million | -57.87 Million | -48.7 Million |
| Investment purchases | - | - | - | -1.05 Billion | - | -485.9 Million |
| Sales/Maturities of investments | - | - | - | 1.19 Billion | - | 628.29 Million |
| Other Investing Activities | -3.33 Million | -3.33 Million | 19.09 Million | -453 Thousand | 19.09 Million | 50.36 Million |
| Financing Cash Flow | -99.05 Million | -99.05 Million | 2.42 Million | -55.56 Million | 2.42 Million | -30.2 Million |
| Debt repayment | - | - | - | -35.24 Million | - | -16.33 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -99.05 Million | -99.05 Million | 2.42 Million | -26.86 Million | 2.42 Million | -30.2 Million |
| Accounts receivables | - | - | -8.08 Million | -16.16 Million | -8.08 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | 7.38 Million | 14.77 Million | 7.38 Million | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | 37 Thousand | 264.33 Million | 37 Thousand | 299.34 Million |
| Cash at end of period | -99.62 Million | -99.62 Million | 10.11 Million | 305.17 Million | 10.11 Million | 345.76 Million |
| Capital Expenditure | -24.63 Million | -24.63 Million | -24.25 Million | -130.88 Million | -24.25 Million | -41.18 Million |
| Effect of forex changes on cash | -54 Thousand | -54 Thousand | -118.5 Thousand | -74 Thousand | -118.5 Thousand | 81.5 Thousand |
| Net cash flow / Change in cash | -99.62 Million | -99.62 Million | 10.07 Million | 40.83 Million | 10.07 Million | 46.42 Million |
| Free Cash Flow | -247 Thousand | -247 Thousand | 46.55 Million | 73.31 Million | 46.55 Million | -9.89 Million |
DASTF
002189
SIGC
000564
EKAD
LEMONTREE